MRTFA and cyclic hematopoiesis: After 6 days of treatment, collagen II and I, their regulator myocardin-related transcription factor A (MRTF-A) and phosphorylated-Sox9 (pSox9), cell shape descriptors, F-actin cytoskeleton, vinculin, and inflammatory-related interleukin-6/10 were analyzed to reveal the mechanism underlying the effects of AITC treatment on CH phenotype.